DRAGARWQ logo

Dr Agarwals Eye Hospital Limited

DRAGARWQ·NSE·
₹5,170.00▲ +22.00 (+0.43%)
Market Cap2465.06 Cr
PE Ratio44.46
Volume579
Day High - Low5200.00 - 5110.00
52W High-Low6059.70 - 4600.00

Dr Agarwals Eye Hospital Limited (DRAGARWQ): company summary

The company's business is growing, with annual revenue rising 24.5% and annual net profit increasing 19.6%.

Dr Agarwals Eye Hospital Limited (DRAGARWQ) is a micro-cap Healthcare company valued at ₹2,465 crore operating in Hospital on the NSE and BSE.

Recent price move
Dr Agarwals Eye Hospital Limited last traded at ₹5,170, modestly up 0.43% on the day.
Recent developments
On 2026-09-02, the company announced a dividend of ₹4.00 per share, ex-date. The domestic institutional holding decreased by 0.07 percentage points in the latest quarter.
Financial performance
The company's business is growing, with annual revenue rising 24.5% and annual net profit increasing 19.6%. The latest quarter saw revenue rise 22.2% and net profit jump 35.3% compared to the same quarter a year earlier, though the net profit margin narrowed slightly to 13.9% from 14.4%.
Valuation multiples
The stock trades at 44.5 times earnings, a premium to the Healthcare median of 32.0, 7.42 times book value. It yields 0.1%.
Things to watch
The stock is 14.9% below its 52-week high, and the net profit margin has narrowed by 0.6 percentage points. The debt to equity ratio stands at 1.59, indicating a moderate level of leverage.
Where it stands
Dr. Agarwal's Eye Hosp L has shown strong growth in both revenue and net profit over the past year and quarter, with a notable rise in net profit. The stock remains below its 52-week high, and the net profit margin has slightly declined, which is the most significant reported figure.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
5.7/10
Fair
Fair Value
Sign in to see
ROE
26.19%
Strong
P/E
44.46x
Expensive
Debt / Equity
1.59
High
Industry
Healthcare
Hospital
Overall View
Mixed

Price performance

Day₹5110
₹5200
52W₹4600
₹6060
DocStoX take

Supported by growth (9.5) and quality (7.9), but held back by valuation (0.1). Growth looks strong at 9.5, but that is offset by valuation at 0.1. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
5.7
/10
Fair
Quality
Excellent
ROE 26.2%
Valuation
Expensive
P/E 44.5×
Growth
Strong
Revenue +27.5% 5Y CAGR
Risk
Moderate
D/E 1.59
Momentum
Soft
39% of 52-week range

At a glance

Market Cap
₹2,465 Cr
52W High / Low
₹6060 / ₹4600
Dividend Yield
0.13%
Promoter Holding
72.67%
EPS (TTM)
₹116.28
Book Value
₹443.98

Key highlights

  • Profitable in all of the last 5 years
  • Revenue compounding 27% a year
  • Strong returns on equity (26%)
  • High leverage — debt is 1.6× equity
  • Valuation is weak (0.1/10)
4 Positives2 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Hospital

Dr Agarwals Eye Hospital Limited peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.